These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36283008)

  • 1. The role of serotonin in pathogenesis of unclassified irritable bowel syndrome.
    Chojnacki C; Konrad P; Kaczka A; Mędrek-Sochab M; Chojnacki M; Błońska A
    Pol Merkur Lekarski; 2022 Oct; 50(299):277-281. PubMed ID: 36283008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites.
    Chojnacki C; Medrek-Socha M; Blonska A; Zajdel R; Chojnacki J; Poplawski T
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome.
    Chojnacki C; Błońska A; Konrad P; Chojnacki M; Podogrocki M; Poplawski T
    Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in serotonin metabolism in the irritable bowel syndrome.
    Thijssen AY; Mujagic Z; Jonkers DM; Ludidi S; Keszthelyi D; Hesselink MA; Clemens CH; Conchillo JM; Kruimel JW; Masclee AA
    Aliment Pharmacol Ther; 2016 Jan; 43(2):272-82. PubMed ID: 26538292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is melatonin involved in the irritable bowel syndrome?
    Radwan P; Skrzydlo-Radomanska B; Radwan-Kwiatek K; Burak-Czapiuk B; Strzemecka J
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():67-70. PubMed ID: 19996484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melatonin secretion and metabolism in patients with irritable bowel syndrome].
    Stepień A; Moskwa-Fortuna A; Wisniewska-Jarosińska M; Harasiuk A; Chojnacki J
    Pol Merkur Lekarski; 2009 May; 26(155):440-3. PubMed ID: 19606692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome.
    Chojnacki C; Walecka-Kapica E; Mokwinska M; Romanowski M; Pawlowicz M; Chojnacki J; Klupinska G
    J Physiol Pharmacol; 2013 Apr; 64(2):177-83. PubMed ID: 23756392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
    Chojnacki C; Walecka-Kapica E; Lokieć K; Pawłowicz M; Winczyk K; Chojnacki J; Klupińska G
    Endokrynol Pol; 2013; 64(2):114-20. PubMed ID: 23653274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome.
    Wisniewska-Jarosinska M; Chojnacki J; Konturek S; Brzozowski T; Smigielski J; Chojnacki C
    J Physiol Pharmacol; 2010 Jun; 61(3):295-300. PubMed ID: 20610859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Variability of Tryptophan Metabolism in Patients with Mixed Type of Irritable Bowel Syndrome.
    Chojnacki J; Konrad P; Mędrek-Socha M; Kaczka A; Błońska A; Zajdel R; Chojnacki C; Gąsiorowska A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome].
    Tsukanov VV; Rzhavicheva OS; Vasjutin AV; Dunaevskaja OV; Tonkih JL; Bronnikova EP
    Ter Arkh; 2016; 88(8):40-45. PubMed ID: 27636926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
    Patel A; Hasak S; Cassell B; Ciorba MA; Vivio EE; Kumar M; Gyawali CP; Sayuk GS
    Aliment Pharmacol Ther; 2016 Aug; 44(3):246-58. PubMed ID: 27240555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
    Lu WZ; Gwee KA; Moochhalla S; Ho KY
    Aliment Pharmacol Ther; 2005 Nov; 22(10):927-34. PubMed ID: 16268966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.